Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5

Journal of Reproductive Immunology

Volumn 95, Issue 1-2, 2012, Pages 27-35

  Qu, Xiao Wu ^a   Jilling, Tamas ^a   Neerhof, Mark G ^a,b   Luo, Kehuan ^a   Hirsch, Emmet ^a,b   Thaete, Larry G ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Fetal growth restriction; Inflammation; Mouse; Myeloperoxidase; Placenta; Uterus

Indexed keywords

COMPLEMENT COMPONENT C5; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FETUS; FETUS WASTAGE; FETUS WEIGHT; INTRAUTERINE GROWTH RETARDATION; ISCHEMIA; MOUSE; NONHUMAN; OVARY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REPERFUSION; SURVIVAL; UTERINE ARTERY; UTERINE ISCHEMIA; WILD TYPE;

ANIMALS; COMPLEMENT C5; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; FETAL DEATH; FETAL GROWTH RETARDATION; HUMANS; MICE; MICE, MUTANT STRAINS; PEROXIDASE; PLACENTA; PREGNANCY; REPERFUSION INJURY; UTERUS;

EID: 84865531345     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.04.005     Document Type: Article

References (38)

1. Arumugam T.V., Shiels I.A., Woodruff T.M., Granger D.N., Taylor S.M. The role of the complement system in ischemia-reperfusion injury. Shock 2004, 21:401-409.
2. Carter A.M., Enders A.C., Jones C.J., Mess A., Pfarrer C., Pijnenborg R., et al. Comparative placentation and animal models: patterns of trophoblast invasion - a workshop report. Placenta 2006, 27(Suppl. A):S30-S33.
3. Castellano G., Melchiorre R., Loverre A., Ditonno P., Montinaro V., Rossini M., et al. Therapeutic targeting of classical and lectin pathways of complement protects from ischemia-reperfusion-induced renal damage. Am. J. Pathol. 2010, 176:1648-1659.
4. Cervera A., Planas A.M., Justicia C., Urra X., Jensenius J.C., Torres F., et al. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 2010, 5:e8433.
5. Chow W.N., Lee Y.L., Wong P.C., Chung M.K., Lee K.F., Yeung W.S. Complement 3 deficiency impairs early pregnancy in mice. Mol. Reprod. Dev. 2009, 76:647-655.
6. Cohen D., Buurma A., Goemaere N.N., Girardi G., le Cessie S., Scherjon S., et al. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J. Pathol. 2011, 225:502-511.
7. Derzsy Z., Prohaszka Z., Rigo J., Fust G., Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol. Immunol. 2010, 47:1500-1506.
8. Facchinetti F., Alberico S., Benedetto C., Cetin I., Cozzolino S., Di Renzo G.C., et al. A multicenter, case-control study on risk factors for antepartum stillbirth. J. Matern. Fetal Neonatal Med. 2010, 24:407-410.
9. Garite T.J., Clark R., Thorp J.A. Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am. J. Obstet. Gynecol. 2004, 191:481-487.
10. Girardi G., Yarilin D., Thurman J.M., Holers V.M., Salmon J.E. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 2006, 203:2165-2175.
11. Huber-Lang M., Sarma J.V., Zetoune F.S., Rittirsch D., Neff T.A., McGuire S.R., et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 2006, 12:682-687.
12. Ishimoto H., Natori M., Tanaka M., Miyazaki T., Kobayashi T., Yoshimura Y. Role of oxygen-derived free radicals in fetal growth retardation induced by ischemia-reperfusion in rats. Am. J. Physiol. Heart Circ. Physiol. 1997, 272:H701-H705.
13. Lee H., Green D.J., Lai L., Hou Y.J., Jensenius J.C., Liu D., et al. Early complement factors in the local tissue immunocomplex generated during intestinal ischemia/reperfusion injury. Mol. Immunol. 2010, 47:972-981.
14. Low J.A., Handley-Derry M.H., Burke S.O., Peters R.D., Pater E.A., Killen H.L., et al. Association of intrauterine fetal growth retardation and learning deficits at age 9 to 11 years. Am. J. Obstet. Gynecol. 1992, 167:1499-1505.
15. Malle E., Furtmuller P.G., Sattler W., Obinger C. Myeloperoxidase: a target for new drug development?. Br. J. Pharmacol. 2007, 152:838-854.
16. Mayhew T.M., Charnock-Jones D.S., Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004, 25:127-139.
17. Miyakoshi K., Ishimoto H., Nishimura O., Tanigaki S., Tanaka M., Miyazaki T., et al. Role of leukocytes in uterine hypoperfusion and fetal growth retardation induced by ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1215-H1221.
18. Neerhof M.G., Silver R.K., Caplan M.S., Thaete L.G. Endothelin-1-induced placental and fetal growth restriction in the rat. J. Maternal-Fetal Med. 1997, 6:125-128.
19. Ogunyemi D., Jackson U., Buyske S., Risk A. Clinical and pathologic correlates of stillbirths in a single institution. Acta Obstet. Gynecol. Scand. 1998, 77:722-728.
20. Piper J.M., Xenakis E.M.-J., McFarland M., Elliott B.D., Berkus M.D., Langer O. Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants?. Obstet. Gynecol. 1996, 87:169-174.
21. Qu X., Huang L., Burthart T., Crawford S.E., Caplan M.S., Hsueh W. Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. Prostaglandins 1996, 51:249-262.
22. Rampersad R., Barton A., Sadovsky Y., Nelson D.M. The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro. Placenta 2008, 29:855-861.
23. Redecha P., van Rooijen N., Torry D., Girardi G. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009, 113:4101-4109.
24. Remick D.G., Strieter R.M., Eskandari M.K., Nguyen D.T., Genord M.A., Raiford C.L., et al. Role of tumor necrosis factor-alpha in lipopolysaccharide-induced pathologic alterations. Am. J. Pathol. 1990, 136:49-60.
25. Salafia C.M., Minior V.K., Pezzullo J.C., Popek E.J., Rosenkrantz T.S., Vintzileos A.M. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am. J. Obstet. Gynecol. 1995, 173:1049-1057.
26. Salmon J.E., Girardi G., Holers V.M. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 2003, 12:535-538.
27. Shamonki J.M., Salmon J.E., Hyjek E., Baergen R.N. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am. J. Obstet. Gynecol. 2007, 196. 167.e1-167.e5.
28. Sung I.-K., Vohr B., Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: Comparison with control subjects matched by birth weight and gestational age. J. Pediatr. 1993, 123:618-624.
29. Ten V.S., Yao J., Ratner V., Sosunov S., Fraser D.A., Botto M., et al. Complement component c1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury. J. Neurosci. 2010, 30:2077-2087.
30. Thaete L.G., Kushner D.M., Dewey E.R., Neerhof M.G. Endothelin and the regulation of uteroplacental perfusion in nitric oxide synthase inhibition-induced fetal growth restriction. Placenta 2005, 26:242-250.
31. Thaete L.G., Neerhof M.G. Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. Am. J. Obstet. Gynecol. 2006, 194:1377-1383.
32. Thaete L.G., Neerhof M.G., Caplan M.S. Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat. Am. J. Obstet. Gynecol. 1997, 176:73-76.
33. Thaete L.G., Neerhof M.G., Jilling T., Caplan M.S. Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. J. Soc. Gynecol. Investig. 2003, 10:145-150.
34. Xu D.Z., Zaets S.B., Chen R., Lu Q., Rajan H., Yang X., et al. Elimination of C5aR prevents intestinal mucosal damage and attenuates neutrophil infiltration in local and remote organs. Shock 2009, 31:493-499.
35. Yu G., Sun Y., Foerster K., Manuel J., Molina H., Levy G.A., et al. LPS-induced murine abortions require C5 but not C3, and are prevented by upregulating expression of the CD200 tolerance signaling molecule. Am. J. Reprod. Immunol. 2008, 60:135-140.
36. Zhang H., Qin G., Liang G., Li J., Barrington R.A., Liu D.X. C5aR-mediated myocardial ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 2007, 357:446-452.
37. Zheng X., Zhang X., Feng B., Sun H., Suzuki M., Ichim T., et al. Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am. J. Pathol. 2008, 173:973-980.
38. Zipfel P.F. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 2009, 126:1-7.